Saurabh Agarwal

10PUBLICATIONS
12CO-AUTHORS
Molecular targetsPredictive and prognostic markersInfant and child healthMedical molecular engineering of nucleic acids and proteinsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 29, 2025
Direct Targeting of CXCR2 Receptor Inhibits Neuroblastoma Growth: An In Vitro Assessment.

Rameswari Chilamakuri, Deepika Godugu, Saurabh Agarwal

|Oct 16, 2025
Striking at Survivin: YM-155 Inhibits High-Risk Neuroblastoma Growth and Enhances Chemosensitivity.

Danielle C Rouse, Rameswari Chilamakuri, Saurabh Agarwal

|Oct 26, 2024
Repurposing of c-MET Inhibitor Tivantinib Inhibits Pediatric Neuroblastoma Cellular Growth.

Rameswari Chilamakuri, Saurabh Agarwal

|Jul 29, 2023
Pediatric Cancers: Insights and Novel Therapeutic Approaches.

Saurabh Agarwal

|Nov 26, 2022
ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo.

Yang Yu, Yanling Zhao, Jongmin Choi

|Oct 14, 2022
Exploring Amodiaquine's Repurposing Potential in Breast Cancer Treatment-Assessment of In-Vitro Efficacy & Mechanism of Action.

Vineela Parvathaneni, Rameswari Chilamakuri, Nishant S Kulkarni

Pageof 2

Frequent Collaborators

7 joint publications

Rameswari Chilamakuri

1 joint publications

Nabeela F Baig

1 joint publications

Vivek Gupta

1 joint publications

Yanling Zhao